MedTrace Logo

The MAI-FOIE Cohort

NCT07594990 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2026-05-19

No results posted yet for this study

Summary

The MAI-FOIE cohort will be a French multicenter cohort with the development of a biobank including patients with autoimmune, metabolic and medicated liver diseases

Conditions

  • Autoimmune Liver Diseases
  • Immunological Mechanisms

Sponsors & Collaborators

  • Direction Générale de l'Offre de Soins

    collaborator OTHER_GOV

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • National Cancer Institute, France

    collaborator OTHER_GOV

  • Association Française pour l'Etude du Foie (AFEF)

    collaborator UNKNOWN

  • ALBI

    collaborator UNKNOWN

  • FILFOIE

    collaborator UNKNOWN

  • GIRCIGO

    collaborator UNKNOWN

  • CR2TI-U1064

    collaborator UNKNOWN

  • HEPATIM-GO network

    collaborator UNKNOWN

  • CIC IMAD

    collaborator UNKNOWN

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2028-05-30
Completion
2038-05-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07594990 on ClinicalTrials.gov